Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Total Voting Rights


Posted on: 03 Oct 16
3 October 2016 15:00 Transparency Directive Voting Rights and Capital The following notification is made in accordance with the UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1. On 30 September 2016 the issued share capital of AstraZeneca PLC with voting rights is 1,265,021,933 ordinary shares of US$0.25. No shares are held in Treasury. Therefore, the total number of voting rights in AstraZeneca PLC is 1,265,021,933. The above figure for the total number of voting rights may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, AstraZeneca PLC under the UK Financial Conduct Authority's Disclosure and Transparency Rules. About AstraZeneca AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Respiratory and Autoimmunity, Cardiovascular and Metabolic Diseases, and Oncology. The Company is also active in inflammation, infection and neuroscience through numerous collaborations. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. For more information please visit: www.astrazeneca.com CONTACTS Media   Enquiries Neil   Burrows UK/Global +44 203 749 5637 Vanessa   Rhodes UK/Global +44 203 749 5736 Karen   Birmingham UK/Global +44 203 749 5634 Rob   Skelding UK/Global +44 203 749 5821 Jacob   Lund Sweden +46 8 553 260 20 Michele   Meixell US +1 302 885 2677 Investor Relations UK Thomas Kudsk Larsen +44 203 749 5712 Craig   Marks Finance,   Fixed Income, M&A +44 7881 615 764 Nick   Stone Respiratory   & Autoimmunity +44 203 749 5716 Henry   Wheeler Oncology +44 203 749 5797 Christer   Gruvris Infection   & Neuroscience +44 203 749 5711 US Lindsey   Trickett Cardiovascular   & Metabolic Diseases +1 240 543 7970 Mitchell   Chan Oncology +1 240 477 3771 Toll-free +1 866 381 7277 Adrian Kemp Company Secretary AstraZeneca PLC -ENDS-GlobeNewswire
globenewswire.com

Last updated on: 04/10/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.